BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2904450)

  • 1. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.
    Newcom SR; Kadin ME; Ansari AA; Diehl V
    J Clin Invest; 1988 Dec; 82(6):1915-21. PubMed ID: 2904450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
    Newcom SR; Tagra KK
    Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of monoclonal antibodies that detect Hodgkin's high molecular weight transforming growth factor-beta.
    Newcom SR; Muth LH; Parker ET
    Blood; 1990 Jun; 75(12):2434-7. PubMed ID: 1693533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.
    Newcom SR; Kadin ME; Ansari AA
    Am J Pathol; 1988 Jun; 131(3):569-77. PubMed ID: 2898211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
    Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
    Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.
    Newcom SR; Gu L
    J Clin Pathol; 1995 Feb; 48(2):160-3. PubMed ID: 7745117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.
    Kadin M; Butmarc J; Elovic A; Wong D
    Am J Pathol; 1993 Jan; 142(1):11-6. PubMed ID: 8424449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
    Newcom SR; Tagra KK; Kadin ME
    Am J Pathol; 1992 Mar; 140(3):709-18. PubMed ID: 1312308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
    Keski-Oja J; Lyons RM; Moses HL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.
    Massagué J; Kelly B
    J Cell Physiol; 1986 Aug; 128(2):216-22. PubMed ID: 2874147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants.
    Paietta E; Racevskis J; Stanley ER; Andreeff M; Papenhausen P; Wiernik PH
    Cancer Res; 1990 Apr; 50(7):2049-55. PubMed ID: 2156611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell.
    Newcom SR; Kadin ME; Phillips C
    Int J Cell Cloning; 1988 Nov; 6(6):417-31. PubMed ID: 3230329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of fibroblast growth by nodular sclerosing Hodgkin's disease cell cultures.
    Newcom SR; O'Rourke L
    Blood; 1982 Jul; 60(1):228-37. PubMed ID: 6211204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hodgkin's cell in nodular sclerosis does not release interleukin-1.
    Newcom SR
    J Lab Clin Med; 1985 Feb; 105(2):170-7. PubMed ID: 3871830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
    Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
    Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins.
    Jennings JC; Mohan S
    Endocrinology; 1990 Feb; 126(2):1014-21. PubMed ID: 2137079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
    Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
    Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the latent transforming growth factor beta complex in bone.
    Pfeilschifter J; Bonewald L; Mundy GR
    J Bone Miner Res; 1990 Jan; 5(1):49-58. PubMed ID: 2309578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.